
News|Videos|October 17, 2025
AAO 2025: Insights on the PULSAR extension study
Author(s)Hattie Hayes
Jean-Francois Korobelnik, MD, shares highlights from the PULSAR extension study showcasing aflibercept 8 mg and its ability to promote fluid resolution
Advertisement
Ahead of the 2025 American Academy of Ophthalmology (AAO) meeting in Orlando, Florida, the Eye Care Network spoke with Jean-Francois Korobelnik, MD. Prof Korobelnik, of Hôpital Pellegrin and CHU de Bordeaux, Bordeaux, France, is an editorial advisor for
In this video, Prof Korobelnik discusses the fluid resolution outcomes observed in the study, describes the accompanying functional outcomes and patient response, addresses possible areas of future study and shares his perspective on the changing landscape of retinal therapies.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Bayer acquires Perfuse Therapeutics, partners with Iambic to expand ophthalmology and AI capabilities
2
Memento Medicines launches with $93 million Series A to advance Tie2-activating bispecific for retinal disease
3
Obstructive sleep apnea and glaucoma: What a 12.5-million-patient data set reveals
4
Meta's AI glasses for veterans: Canto-Sims, OD on closing the access gap
5


























